Maryland Room • Located on the Lobby Level of Marriott Wardman Park
Tuesday, September 10, 2019 • 12:00 PM – 1:00 PM – Lunch Session
Title: Addressing the Needs of Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Sponsor: Pharmacy Times Continuing Education™
Description: Atopic dermatitis is the most common form of eczema affecting the pediatric and adolescent population. This inflammatory skin disorder manifests in skin creases as erythema and dryness with the hallmark symptom being pruritus. The appearance of these skin lesions and subsequent itching can have a significant effect on patients’ quality of life. Treatment is multifaceted and incorporates nonpharmacologic strategies and pharmacologic therapies, including topical, oral, and subcutaneous agents. Specialty pharmacists need to understand the underlying pathophysiology of the disease and be aware of the current treatment landscape to effectively counsel and monitor therapeutic clinical outcomes.
Supporter: This activity is supported by educational grants from Sanofi Genzyme and Regeneron Pharmaceuticals.
For more information, go to https://www.pharmacytimes.org/live/nasp-atopic-dermatitis.